159 related articles for article (PubMed ID: 11552898)
21. Acute pancreatitis and the role of histamine-2 receptor antagonists: a meta-analysis of randomized controlled trials of cimetidine.
Morimoto T; Noguchi Y; Sakai T; Shimbo T; Fukui T
Eur J Gastroenterol Hepatol; 2002 Jun; 14(6):679-86. PubMed ID: 12072603
[TBL] [Abstract][Full Text] [Related]
22. Treatment of refractory peptic ulcer with omeprazole or continued H2 receptor antagonists: a controlled clinical trial.
Bardhan KD; Naesdal J; Bianchi Porro G; Petrillo M; Lazzaroni M; Hinchliffe RF; Thompson M; Morris P; Daly MJ; Carroll NJ
Gut; 1991 Apr; 32(4):435-8. PubMed ID: 1673953
[TBL] [Abstract][Full Text] [Related]
23. Randomized, double-blind, placebo-controlled crossover trial of cimetidine and pirenzepine in nonulcer dyspepsia.
Talley NJ; McNeil D; Hayden A; Piper DW
Gastroenterology; 1986 Jul; 91(1):149-56. PubMed ID: 3519348
[TBL] [Abstract][Full Text] [Related]
24. Chewable cimetidine versus chewable antacid in dyspepsia: which provides faster pain relief?
Parr SN
Curr Med Res Opin; 1989; 11(9):557-66. PubMed ID: 2692970
[TBL] [Abstract][Full Text] [Related]
25. Systematic review: the methodological quality of trials affects estimates of treatment efficacy in functional (non-ulcer) dyspepsia.
Abraham NS; Moayyedi P; Daniels B; Veldhuyzen Van Zanten SJ
Aliment Pharmacol Ther; 2004 Mar; 19(6):631-41. PubMed ID: 15023165
[TBL] [Abstract][Full Text] [Related]
26. The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis.
Lin PC; Chang CH; Hsu PI; Tseng PL; Huang YB
Crit Care Med; 2010 Apr; 38(4):1197-205. PubMed ID: 20173630
[TBL] [Abstract][Full Text] [Related]
27. Double-blind, placebo-controlled trial of famotidine in children with abdominal pain and dyspepsia: global and quantitative assessment.
See MC; Birnbaum AH; Schechter CB; Goldenberg MM; Benkov KJ
Dig Dis Sci; 2001 May; 46(5):985-92. PubMed ID: 11341669
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic options in nonulcer dyspepsia.
Talley NJ
J Clin Gastroenterol; 2001 Apr; 32(4):286-93. PubMed ID: 11276271
[TBL] [Abstract][Full Text] [Related]
29. Meta-analysis: proton pump inhibitors vs. H2-receptor antagonists--their efficacy with antibiotics in Helicobacter pylori eradication.
Gisbert JP; Khorrami S; Calvet X; Gabriel R; Carballo F; Pajares JM
Aliment Pharmacol Ther; 2003 Oct; 18(8):757-66. PubMed ID: 14535868
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological interventions for non-ulcer dyspepsia.
Soo S; Moayyedi P; Deeks J; Delaney B; Innes M; Forman D
Cochrane Database Syst Rev; 2000; (2):CD001960. PubMed ID: 10796840
[TBL] [Abstract][Full Text] [Related]
31. Therapy for Helicobacter pylori in patients with nonulcer dyspepsia. A meta-analysis of randomized, controlled trials.
Laine L; Schoenfeld P; Fennerty MB
Ann Intern Med; 2001 Mar; 134(5):361-9. PubMed ID: 11242496
[TBL] [Abstract][Full Text] [Related]
32. Are frequent short gastro-oesophageal reflux episodes the cause of symptoms in patients with non-ulcer dyspepsia responding to treatment with ranitidine?
Farup PG; Hovde O; Breder O
Scand J Gastroenterol; 1995 Sep; 30(9):829-32. PubMed ID: 8578179
[TBL] [Abstract][Full Text] [Related]
33. [Drug therapy of non-ulcer dyspepsia].
Bytzer P
Ugeskr Laeger; 1991 Aug; 153(32):2212-6. PubMed ID: 1679263
[TBL] [Abstract][Full Text] [Related]
34. Functional dyspepsia. Current treatment recommendations.
Holtmann G; Talley NJ
Drugs; 1993 Jun; 45(6):918-930. PubMed ID: 7691499
[TBL] [Abstract][Full Text] [Related]
35. Cisapride compared with ranitidine in the treatment of functional dyspepsia.
Carvalhinhos A; Fidalgo P; Freire A; Matos L
Eur J Gastroenterol Hepatol; 1995 May; 7(5):411-7. PubMed ID: 7614103
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies).
Talley NJ; Meineche-Schmidt V; Paré P; Duckworth M; Räisänen P; Pap A; Kordecki H; Schmid V
Aliment Pharmacol Ther; 1998 Nov; 12(11):1055-65. PubMed ID: 9845395
[TBL] [Abstract][Full Text] [Related]
37. [Symptomatic treatment of dyspepsia in patients with digestive system diseases].
Tkachev AV
Eksp Klin Gastroenterol; 2006; (6):56-60. PubMed ID: 17612097
[No Abstract] [Full Text] [Related]
38. [Are proton pump inhibitors superior to H2 receptor antagonists within the scope of H. pylori eradication therapy? Meta analysis of current parallel group comparisons].
Holtmann G; Layer P; Goebell H
Z Gastroenterol; 1996 May; 34(5):267-72. PubMed ID: 8686357
[TBL] [Abstract][Full Text] [Related]
39. Incidence of postoperative dyspepsia is not associated with prophylactic use of drugs.
Tsuchie SY; Nani FS; Vieira JE
Sao Paulo Med J; 2014; 132(4):219-23. PubMed ID: 25055067
[TBL] [Abstract][Full Text] [Related]
40. Functional dyspepsia: where do we stand?
Lamers CB
Scand J Gastroenterol Suppl; 1993; 200():96-7. PubMed ID: 7912448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
